TELA Bio (TELA) is scheduled to report Q2 earnings on August 10, 2026. Analysts estimate EPS of $-0.18 and quarterly revenue of $20.01M.
In the most recent quarter (Q1), TELA Bio reported EPS of $-0.21, missing estimates of $-0.18 by 0.17%. Revenue came in at $19.06M, exceeding the estimate of $18.90M by 0.01%.
Over the last 4 quarters, TELA Bio has averaged an EPS surprise of 0.11% and a revenue surprise of 0.02%.
Earnings Date
Aug 10
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$20.01M
Annual Revenue
$80.81M
as of Mar 31
Analyze the earnings history of TELA Bio using advanced sorting and filters.
The chart below shows TELA Bio's reported EPS compared to analyst estimates over recent quarters.
The chart below shows TELA Bio's reported revenue compared to analyst estimates over recent quarters.
TELA Bio (TELA) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
The Actual EPS was $-0.21, which missed the estimate of $-0.18.
The Actual Revenue was $19.06M, which beat the estimate of $18.90M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $-0.21 | $-0.18 | -16.7 % |
| Q4 | Mar 24, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 13, 2025 | $-0.19 | $-0.19 | 0.00 % |
| Q2 | Aug 11, 2025 | $-0.22 | $-0.18 | -22.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $19.06M | $18.90M | 0.84 % |
| Q4 | Mar 24, 2026 | $20.87M | $21.02M | -0.74 % |
| Q3 | Nov 13, 2025 | $20.70M | $21.83M | -5.17 % |
| Q2 | Aug 11, 2025 | $20.20M | $20.62M | -2.06 % |